The effectiveness of the combination of oVV-ING4 and cytarabine was examined both in vitro and in vivo; it dramatically reduced leukemia cell survival in vitro and decreased the growth of a xenografted KG-1 AML tumor in vivo. The gene discussed is ING4; the disease is neoplasm.